Introduction
As the absorbed dose to soft tissue from intracavitary applications is so highly nonuniform throughout the target volume, the concepts of maximum, mean, median and modal target absorbed dose, as defined in ICRU Report 29 (ICRU 1978) , are not relevant. The minimum target absorbed dose is the only useful concept and is, by definition, equal to the treatment absorbed dose level.
For external beam therapy, it has been recommended that the target absorbed dose be the absorbed dose at one or more specification points which are representative of the dose distribution throughout the target volume. These specification points could be established with respect to the target volume or to the beam axes, or both.
The situation is more difficult in intracavitary therapy due to the steep dose gradient in the vicinity of the sources, i.e., throughout the tumor or the target volume. Under these conditions, the specification of the target absorbed dose in terms of the absorbed dose at specific point(s), in the vicinity of the sources, becomes less meaningful and a different approach is required. Instead of a target-dose specification, a volume specification is recommended.
Specification of an intracavitary application in terms of the "reference volume" enclosed by the reference isodose surface is proposed in this Report. However, as the different isodose surfaces are close to each other, the indication of the reference volume must be supplemented, for safety reasons, by the indication of the total reference air kerma which, for radium treatments, is proportional to the number of "mg·h". In addition, a record of absorbed dose at reference points related to organs at risk or to bony structures is recommended. The time-dose pattern shall also be clearly indicated (see Section 4).
The present recommendations do not imply a modification of the method used for the calculation of the treatment duration, but they imply the calculation of specific quantities to be determined for reporting.
The recommendations presented in this Report must be considered a minimum requirement for reporting. On the other hand, the reported parameters will be meaningful only to the extent that the technique of the particular intracavitary application has been completely described.
This report deals mainly with the treatment of cervix carcinoma for which the anatomical region of interest is similar for every patient and the possible variation in 9 the position of the radioactive sources is limited. However, for other gynecological intracavitary situations the same philosophy can be adopted, but some of the numerical values and definitions may need to be modified according to the type of application.
Description of the Technique
It is recommended that the technique be described on the basis of the guidance given below.
The Sources (i) radionuclide;
(ii) reference air kerma rates; (iii) shape, filtration, etc.
3.2.2
Simulation of Linear Sources a) When a linear source is simulated by a set of point sources, the activity of these point sources and their separation(s) must be indicated. b) When moving sources are used to simulate a set of different sources in fixed position, in order to produce an appropriate dose distribution, the following indications are required: (i) type of movement (continuous or stepwise, step distance); (ii) unidirectional or oscillating movement; (iii) range of movement or oscillation; (iv) speed in different sections of the applicator, or dwell times of the source at different positions.
The Applicator
Reference to the applicator is sufficient when a complete description has already been published, provided that there is no significant difference between the applicator used and the one described in the literature. To avoid confusion, it is recommended that the applicator be described, including the name of the manufacturer. The description should include information on the following points: (i) rigid (or not), consequently with fixed known geometry (or not) of the complete applicator; (ii) rigid uterine source with fixed curvature (or not); (iii) connection between vaginal and uterine applicators, i,e., fixed, loose (semi-fixed), free; (iv) type of vaginal sources, number and orientation of line sources, special sources (box, ring, etc.); (v) high atomic number shielding materials in vaginal applicator (or not).
Recommendations for Reporting
Three approaches are proposed to specify intracavitary application for cervix carcinoma; they complement each other and it is recommended that they be combined.
Total Reference Air Kerma
When radium was used exclusively, the product of the "quantity of radioactive material" and the duration of the treatment was given as minimal information. This is the "concept of the mg·h". It becomes increasingly difficult to use the product mg·h for specifying an intracavitary application with other radionuclides, even if milligrams of radium are replaced by the term "milligram-radium equivalent" which can be misleading (see Appendix). As noted in Section 2.3, the use of total reference air kerma is proposed in this Report. This quantity is unambiguous and easy to calculate. It is proportional to the integral dose to the patient and can also serve as a useful index for radiation protection of personnel.
In addition, the inverse square law applied to the total reference air kerma allows evaluation, to a reasonable approximation, of the absorbed dose delivered during treatment at distances from the sources down to 20-10 cm. When the distance of a point P from the center C of the volume occupied by the sources is larger than 2.5 times the largest dimension of that volume, the dose rate obtained at P from the actual distribution of sources differs by less than 4% from that obtained by assuming that all of the sources are located at C (Dutreix et al., 1982) .
However, the simple calculation of the total reference air kerma does not allow one W derive, even roughly, the absorbed dose in the immediate vicinity of the sources (Le., in the tumor or target volume) and, in particular, it should be stressed that an accurate and simple relation cannot be derived between total reference air kerma and absorbed doses at specific points such as A and B (see Figure 1 .3.).
Description of the Reference Volume
The description of the reference volume, i.e., the tissue volume encompassed by a reference isodose surface, is proposed for specification in reporting. The reasons for this approach are described in Sections 2.2.1.,2.2.2. and 3.1.
a. Dose Level
An absorbed dose level of 60 Gy is widely accepted as the appropriate reference level for classical low dose-rate therapy. When two or more intracavitary applications are performed, the absorbed dose to consider is that r~sulting from all applications. The time-Plane a Plane b -. . . . . . . . a Fig. 3 .1. Geometry for measurement of the size of the pear -shaped 60 Gy isodose surface (broken line) in a typical treatment of cervix carcinoma using one rod-shaped uterine applicator and 2 vaginal applicators. Plane a is the "oblique" frontal plane that contains the intrauterine device. The oblique frontal plane is obtained by rotation of the frontal plane around a transverse axis, Plane b is the "oblique" sagittal plane that contains the intrauterine device. The oblique sagittal plane is obtained by rotation of the sagittal plane around AP axis. The height (db) and the width (dw) of the reference volume are measured in plane a as the maximal sizes parallel and perpendicular to the uterine applicator, respectively. The thickness (dt ) of the reference volume is measured in plane b as the maximal size perpendicular to the uterine applicator. dose pattern should be clearly stated (see Section 4.2).
When intracavitary therapy is combined with external beam therapy, the isodose level to be considered is the difference between 60 Gy and the dose delivered at the same location by external beam therapy. For example, if a dose of 20 Gy were delivered to the whole pelvis by external beam therapy, the isodose level to be considered would be 60 -20 Gy = 40 Gy. Nevertheless, it is recognized that the combined dose does not nec-essarily produce the same effect as a similar dose from intracavitary therapy alone. For intracavitary therapy at medium or high dose rates, the therapist has to indicate the dose level which he believes to be equivalent to 60 Gy delivered at the classical low dose rate and should clearly state this. b. Reference Volume: Description of the Pear-Shaped Volume
When uterine source(s) are combined with vaginal sources, or when the uterine source is more heavily loaded at the lower end, the tissue volume to be described presents a pear shape with its longest axis coincident with the intrauterine source. This reference volume is defined by means of three dimensions (see Figure 3 .1): (i) the height (dh) is the maximum dimension along the intrauterine source and is measured in the oblique frontal plane containing the intrauterine source; (ii) the width (dw) is the maximum dimension perpendicular to the intrauterine source and is measured in the same oblique frontal plane; (iii) the thickness (d t ) is the -maximum dimension perpendicular to the intrauterine source and is measured in the oblique sagittal plane containing the intrauterine source. The definitions of dh, d w and dt are proposed in order to minimize the number of calculations. These dimensions are usually expressed in cm. The volume estimated from the intersections of the surface of a pear-shaped volume on two conventional planes does not necessarily represent the size of the true reference volume. However, for most applications they do not differ from the maximum dimensions of the reference volume by more than 1 or 2 mm.
Absorbed Dose at Reference Points
Several reference points are in current use. Some are relatively close to the sources and related either to the sources or to organs at risk; others are relatively far from the sources and are related to bony structures. The following definitions apply to the case where the doses are calculated from two perpendicular radiographs, AP and lateral. When other methods are used, such as stereographic x-ray films, oblique perpendicular radiographs or transverse sections (CT scans), the calculations need to be modified.
a. Reference Points Close to the Sources and Related to the Sources
As such points are located in a region where the dose gradient is high, any inaccuracy in the determination of distance results in large uncertainties in the absorbed doses evaluated at these points. Such calculated absorbed doses do not, therefore, seem an appropriate
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means of characterizing an intracavitary application and/or of specifying the target absorbed dose, particularly if rigid source combinations are not used. Such points are not recommended.
b. Reference Points Relatively Close to the Sources but Related to Organs at Risk
The determination and specification of the absorbed dose to organs at risk (bladder, rectum, etc.) are obviously useful with respect to normal tissue tolerance limits. However, such information will be meaningful only to the extent that it is obtained and expressed in precise and well-codified ways. (i) Calculated Values: Reference points for the expression of the absorbed dose to the bladder and the absorbed dose to the rectum (see Figure 3 .2.) have been proposed by Chassagne and Horiot (1977) .
The bladder reference point is obtained as follows. A Foley catheter is used. The balloon must be filled with 7 cm 3 of radio-opaque fluid. The catheter is pulled downwards to bring the balloon against the urethra. On the lateral radiograph, the reference Fig. 3.3 . Measurement of the rectal dose rate. Following the insertion of the source applicators, either pre-loaded (low-activity treatment) or manually loaded with low-activity sources identical in design to those used during high-activity after-loaded treatment, the rectal dose is measured_ Method A: The measuring probe is moved relative to a rigid guide tube inserted into the rectum and held in position. The point of maximum rectal dose rate is noted and the distance "d" in cm from the anal verge deduced.
Method B: The measuring probe is moved so that the tip of the probe is moved along the mid-line of the recto-vaginal septum until the point of maximum dose rate is reached_ Distance is taken as a direct reading on the central tube at the anal verge. The dose-rate and distance are recorded. The major disadvantage of method" A" is that the probe tip cannot follow closely the surface of the anterior rectal wall. However, allowance for the distance of the probe sensor from the vagino-rectal septum needs to be taken into account. radio-opaque gauze used for the packing. On the AP radiograph, this reference point is at the lower end of the intrauterine source or at the middle of the intravaginal source(s). (ii) Monitoring of the Absorbed Dose Rate to the Rectum.-An alternative to calculating the rectal dose is to measure the dose, or dose rate, at different points along the anterior rectal wall to ensure that no area of the rectal mucosa receives a dose above the tolerance level. This type of measurement requires special care in positioning the measuring probe. An example is given in Figure 3 .3_ (O'Connell et al., 1967; Joslin et al., 1972) . c. Reference Points Related to Bony Structures (i) The lymphatic trapezoid is obtained as follows (see Figure 3 .4): A line is drawn from the junction of 81-82 to the top of the symphysis_ Then a line is drawn from the middle of that line to the middle of the anterior aspect of U. A trapezoid is constructed in a plane passing through the transverse line in the pelvic brim plane and the midpoint of the anterior aspect of the body of L4. A point 6 cm lateral to the midline at the inferior end of this figure is used to give an estimate of the dose rate to mid-external iliac lymph nodes (labeled R. EXT and L. EXT for right and left external, respectively). At the top of the trapezoid, points 2 cm lateral to the midline at the level of L4 are used to estimate the dose to the low para-aortic area (labeled R. PARA and L. PARA). The midpoint of a line connecting these two points is used to estimate the dose to the low common (labeled R. COM and L. COM) iliac lymph nodes (from Fletcher, 1980) . (ii) The pelvic-wall reference point (Chassagne et al., 1977) can be visualized on an AP and a lateral radiograph and related to fixed bony structures. This point is intended to be representative of the absorbed dose at the distal part of the parametrium and at the obturator lymph nodes (see Figure 3 .5.).
On an AP radiograph, the pelvic-wall reference point is intersected by the following two lines: a horizontal line tangential to the highest point of the acetabulum, a vertical line tangential to the inner aspect of the acetabulum. On a lateral radiograph, the highest points of the right and left acetabulum, in the cranio-caudal direction, are joined and the lateral projection of the pelvic-wall reference point is located at the mid-distance of these points. Evaluation of the absorbed dose at reference points, related to well-defined bony structures and lymph node areas, is particularly useful when intracavitary therapy is combined with external beam therapy. It is also useful in helping to avoid an overdose when intracavitary therapy is to be followed by surgery.
Calculation of Dose Distribution
The present recommendation, in particular the description of the reference volume encompassed by the 60-Gy isodose surface, necessitates the computation of complete dose distributions in several planes.
The respective planes for which the dose distribunon is to be computed will depend on the technique IUhl (I.e particular clinical situation. However, as a millimum requirement, it is recommended that the dose distributions be computed in two planes: the oblique frontal plane and the oblique sagittal plane both containing the intrauterine source. When practicable, it is recommended that dose distributions be calculated in additional sets of planes and that these dosimetric data be correlated with that obtained from radiographs or CT sections, in order to determine the absorbed dose at any relevant anatomical point.
While this additional information will be of value in assessing effects in any individual patient, it will also provide: (i) the possibility of comparing the methods of specification used in different centers and of evaluating their respective merits; (ii) the possibility of comparing the methods of specification used in historical series (mg·h, points "A" and "B") with the methods recommended in the present Report; (iii) the possibility of deriving new clinical and radiobiological data and correlations which could improve treatment techniques and develop further the method of specification.
3.4 Definition of the 60 Gy Reference Volume in Special Situations
One Linear Source Only
In some situations only one linear source is present: -in the case of a narrow vagina with a uterine source protruding into the vaginal cavity, -in the case of vaginal irradiation with a central source from a cylindrical applicator. In estimating the volume (Section 3.3.2.b) in this simple case, the width is equal to the thickness.
Vaginal Sources Only
When only vaginal sources are present, width is the largest dimension from right to left in an oblique frontal plane through the main axis of the vagina.
Thickness is the largest dimension in a direction perpendicular to the above oblique plane. Height is measured along the vaginal axis, and is commonly shorter than the other two dimensions.
Rigid Applicator
Provided that there is a fixed connection between vaginal and uterine sources, pre-calculated isodose surfaces can be obtained for given loadings of the applicator. Therefore, pre-calculated dimensions of height, width and thickness can be given (IAEA, 1972) .
Uterine Packing (In Endometrial Cancer)
In connection with uterine packing, the same definitions of height, width and thickness given in Section 3.3.2 can be used. However, two facts need to be noted: -width and thickness are usually located at the level of the uterine fundus (the pear-shaped volume is reversed), -height should be determined in the oblique frontal plane, which gives the maximum dimension.
